Bausch Health Cos Net Income 2010-2023 | BHC
Bausch Health Cos net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Bausch Health Cos Annual Net Income
(Millions of US $) |
| 2023 |
$-592 |
| 2022 |
$-225 |
| 2021 |
$-948 |
| 2020 |
$-560 |
| 2019 |
$-1,788 |
| 2018 |
$-4,148 |
| 2017 |
$2,404 |
| 2016 |
$-2,409 |
| 2015 |
$-292 |
| 2014 |
$881 |
| 2013 |
$-866 |
| 2012 |
$-116 |
| 2011 |
$160 |
| 2010 |
$-208 |
| 2009 |
$176 |
Bausch Health Cos Quarterly Net Income
(Millions of US $) |
| 2023-12-31 |
$-39 |
| 2023-09-30 |
$-378 |
| 2023-06-30 |
$26 |
| 2023-03-31 |
$-201 |
| 2022-12-31 |
$-410 |
| 2022-09-30 |
$399 |
| 2022-06-30 |
$-145 |
| 2022-03-31 |
$-69 |
| 2021-12-31 |
$69 |
| 2021-09-30 |
$188 |
| 2021-06-30 |
$-595 |
| 2021-03-31 |
$-610 |
| 2020-12-31 |
$-153 |
| 2020-09-30 |
$71 |
| 2020-06-30 |
$-326 |
| 2020-03-31 |
$-152 |
| 2019-12-31 |
$-1,516 |
| 2019-09-30 |
$-49 |
| 2019-06-30 |
$-171 |
| 2019-03-31 |
$-52 |
| 2018-12-31 |
$-344 |
| 2018-09-30 |
$-350 |
| 2018-06-30 |
$-873 |
| 2018-03-31 |
$-2,581 |
| 2017-12-31 |
$513 |
| 2017-09-30 |
$1,301 |
| 2017-06-30 |
$-38 |
| 2017-03-31 |
$628 |
| 2016-12-31 |
$-515 |
| 2016-09-30 |
$-1,218 |
| 2016-06-30 |
$-302 |
| 2016-03-31 |
$-374 |
| 2015-12-31 |
$-386 |
| 2015-09-30 |
$50 |
| 2015-06-30 |
$-53 |
| 2015-03-31 |
$98 |
| 2014-12-31 |
$502 |
| 2014-09-30 |
$275 |
| 2014-06-30 |
$126 |
| 2014-03-31 |
$-23 |
| 2013-12-31 |
$124 |
| 2013-09-30 |
$-973 |
| 2013-06-30 |
$11 |
| 2013-03-31 |
$-28 |
| 2012-12-31 |
$-89 |
| 2012-09-30 |
$8 |
| 2012-06-30 |
$-22 |
| 2012-03-31 |
$-13 |
| 2011-12-31 |
$56 |
| 2011-09-30 |
$41 |
| 2011-06-30 |
$56 |
| 2011-03-31 |
$6 |
| 2010-12-31 |
$-31 |
| 2010-09-30 |
$-208 |
| 2010-06-30 |
$34 |
| 2010-03-31 |
$-3 |
| 2009-12-31 |
$73 |
| 2009-09-30 |
$40 |
| 2009-06-30 |
$24 |
| 2009-03-31 |
$39 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.150B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
